United Therapeutics Corp. (UTHR) PT Lowered to $203 at Ladenburg Thalmann
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $500.59 +2.66%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Join SI Premium – FREE
Ladenburg Thalmann analyst Matthew Kaplan lowered the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $203.00 (from $231.00) while maintaining a Buy rating.
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Hyperion DeFi, Inc. (HYPD) PT Raised to $8.45 at Chardan
- Roivant Sciences (ROIV) PT Raised to $52 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
